P Segond

536 total citations
23 papers, 449 citations indexed

About

P Segond is a scholar working on Immunology, Surgery and Rheumatology. According to data from OpenAlex, P Segond has authored 23 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Surgery and 5 papers in Rheumatology. Recurrent topics in P Segond's work include Lipoproteins and Cardiovascular Health (4 papers), Systemic Lupus Erythematosus Research (4 papers) and Diabetes and associated disorders (3 papers). P Segond is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Systemic Lupus Erythematosus Research (4 papers) and Diabetes and associated disorders (3 papers). P Segond collaborates with scholars based in France and United States. P Segond's co-authors include Jaime Levenson, A. Simon, Philippe Giral, M.R. Malinow, F. Javier Nieto, Mahmoud Razavian, Pierre Galanaud, P Massias, J F Delfraissy and J Dormont and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Atherosclerosis.

In The Last Decade

P Segond

21 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Segond France 9 160 146 129 68 58 23 449
Asher Winder Israel 11 134 0.8× 65 0.4× 71 0.6× 75 1.1× 22 0.4× 21 551
Neeraj Das India 11 68 0.4× 77 0.5× 99 0.8× 20 0.3× 19 0.3× 25 350
Antonio Barat Spain 11 54 0.3× 136 0.9× 48 0.4× 14 0.2× 12 0.2× 16 481
Yoshinobu Fuke Japan 13 46 0.3× 46 0.3× 164 1.3× 15 0.2× 10 0.2× 39 498
D. Gouet France 9 44 0.3× 127 0.9× 60 0.5× 32 0.5× 19 0.3× 39 555
Robert L. Seigle United States 10 83 0.5× 31 0.2× 78 0.6× 15 0.2× 19 0.3× 13 591
Pieter Meyer South Africa 14 254 1.6× 34 0.2× 103 0.8× 12 0.2× 59 1.0× 41 538
A Taranta United States 12 50 0.3× 131 0.9× 66 0.5× 7 0.1× 20 0.3× 37 639
G. Barbiano di Belgioioso Italy 7 90 0.6× 38 0.3× 77 0.6× 6 0.1× 30 0.5× 10 565
Edwin H. Jenis United States 15 52 0.3× 63 0.4× 61 0.5× 3 0.0× 34 0.6× 26 517

Countries citing papers authored by P Segond

Since Specialization
Citations

This map shows the geographic impact of P Segond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Segond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Segond more than expected).

Fields of papers citing papers by P Segond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Segond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Segond. The network helps show where P Segond may publish in the future.

Co-authorship network of co-authors of P Segond

This figure shows the co-authorship network connecting the top 25 collaborators of P Segond. A scholar is included among the top collaborators of P Segond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Segond. P Segond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malinow, M.R., Jaime Levenson, Philippe Giral, et al.. (1995). Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis. 114(2). 175–183. 111 indexed citations
2.
Simon, A., et al.. (1993). [Early diagnosis of silent atherosclerosis and detection of cardiovascular risk factors. A new strategy for the approach of cardiovascular prevention].. PubMed. 22(22). 1033–8. 5 indexed citations
3.
Laurier, Dominique, et al.. (1992). Cholesterol and other cardiovascular risk factors in a working population in Ile-De-France (France): First results of the PCV-METRA study. European Journal of Epidemiology. 8(5). 693–701. 11 indexed citations
4.
Cambillau, Michèle, A. Simon, Philippe Giral, et al.. (1992). Serum Lp(a) as a Discriminant Marker of Early Atherosclerotic Plaque at Three Extracoronary Sites in Hypercholesterolemic Men. 12(11). 1346–1352. 42 indexed citations
5.
Cambillau, Michèle, A. Simon, Jacques Amar, et al.. (1992). Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(11). 1346–1352. 66 indexed citations
6.
Priollet, P., et al.. (1985). [Minimal etiological evaluation of Raynaud's phenomenon. 102 cases].. PubMed. 14(39). 1999–2003. 6 indexed citations
7.
Clerc, D, et al.. (1984). [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].. PubMed. 135(6). 420–6. 2 indexed citations
8.
Ellrodt, A., L. Palazzo, Françoise Brun‐Vézinet, et al.. (1984). ISOLATION OF HUMAN T-LYMPHOTROPIC RETROVIRUS (LAV) FROM ZAIRIAN MARRIED COUPLE, ONE WITH AIDS, ONE WITH PRODROMES. The Lancet. 323(8391). 1383–1385. 81 indexed citations
9.
Segond, P, et al.. (1983). Délinquance des jeunes, homeostase familiale et sociale. Bulletin de psychologie. 36(359). 237–247. 2 indexed citations
10.
Segond, P, et al.. (1982). Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.. PubMed. 47(1). 147–54. 8 indexed citations
11.
Segond, P, et al.. (1982). [Attempted therapy of rheumatoid polyarthritis with isoprinosine. Results of an open study of 14 patients].. PubMed. 49(1). 45–9. 1 indexed citations
12.
Segond, P, et al.. (1982). [Severe gastrointestinal manifestations of Henoch-Schönlein purpura in adults (author's transl)].. PubMed. 58(2). 69–72. 6 indexed citations
13.
Galanaud, Pierre, J F Delfraissy, P Segond, & J Dormont. (1980). Acquisitions immunologiques récentes sur la maladie lupique. La Revue de Médecine Interne. 1(2). 147–151. 1 indexed citations
14.
Galanaud, Pierre, et al.. (1980). Vieillissement et auto-immunité Analyse des fonctions lymphocytaires. La Revue de Médecine Interne. 1(1). 11–18. 1 indexed citations
15.
Delfraissy, J F, P Segond, Pierre Galanaud, et al.. (1980). Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.. Journal of Clinical Investigation. 66(1). 141–148. 54 indexed citations
16.
Segond, P, J F Delfraissy, Pierre Galanaud, et al.. (1979). Depressed primary in vitro antibody response in rheumatoid arthritis.. PubMed. 37(2). 196–204. 14 indexed citations
17.
Galanaud, Pierre, Marie‐Claude Crevon, J F Delfraissy, et al.. (1979). Regulation of the primary in vitro antibody response in human peripheral blood lymphocytes: different effects of mitogen-induced and spontaneous T suppressor cells.. PubMed. 38(1). 106–15. 16 indexed citations
18.
Bisson, M, et al.. (1978). [Association of angioimmunoblastic lymphadenopathy and Gougerot-Sjögren syndrome].. PubMed. 7(27). 2393–2393. 4 indexed citations
19.
Segond, P, et al.. (1973). [Narrowing of the bone medullary canal as a dominant trait].. PubMed. 2(41). 2728–32. 2 indexed citations
20.
Segond, P, et al.. (1973). [Alpha heavy chain disease. Apropos of a case].. PubMed. 12(3). 333–49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026